Decentralized Clinical Trials (DCTs), in which clinical trial data is collected through sensors or remote monitoring devices, can deliver many benefits to pharmaceutical companies, including cost savings, better patient recruitment and retention, flexibility in operations, and improved data quality. Before the pandemic, although the technology and data to support DCTs existed, only a few pilots were conducted. Today, the pressing need for remote patient- and site-centric trials has increased investments in DCTs, and the momentum is expected to accelerate going forward, indicating that DCTs are here to stay. Additionally, technology advances, innovative business models, increased wearables support, US FDA’s push to adopt DCTs, and a holistic approach to clinical trials have strengthened the DCT landscape.

In this compendium, we provide comprehensive and fact-based snapshots of 24 DCT platform providers. In addition, each provider is positioned on Everest Group’s PEAK Matrix®; for comparison. The compendium will enable providers to benchmark their capabilities against their competitors, while buyers of DCT platforms will be able to assess the providers based on their desired set of capabilities.

Scope:

Industry: life sciences

Geography: global

Contents:

In this report, we evaluate DCT platform providers on their:

• Market adoption and capabilities
• Case studies and recent developments
• Strengths and limitations
• Sourcing considerations

Membership(s)

Life Sciences Information Technology

Sourcing and Vendor Management